HIF-1α suppresses myeloma progression by targeting Mcl-1

被引:1
|
作者
Wu, Feng [1 ]
Tong, Dong-Dong [2 ]
Ni, Lei [2 ]
Wang, Lu-Min [2 ]
Wang, Meng-Chang [3 ]
机构
[1] Xi An Jiao Tong Univ, Ctr Teaching & Expt Med Post Grad, Sch Med, Xian, Shaanxi, Peoples R China
[2] Xi An Jiao Tong Univ, Sch Basic Med Sci, Dept Cell Biol & Genet, Hlth Sci Ctr, Xian, Shaanxi, Peoples R China
[3] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Hematol, Xian, Shaanxi, Peoples R China
来源
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY | 2020年 / 13卷 / 07期
基金
中国国家自然科学基金;
关键词
HIF-1; alpha; Mcl-1; MMs; proliferation; apoptosis; EPITHELIAL-MESENCHYMAL TRANSITION; CANCER; CELLS; PROLIFERATION; APOPTOSIS; PATHWAY; VEGF;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
HIF-1 alpha is involved in the carcinogenesis and progression of multiple types of cancer. However, the precise role of HIF-1 alpha is unclear in multiple myeloma. Through the qRT-PCR and CCK-8 assays, we demonstrated that silenc-ing the expression of HIF-1 alpha and Mcl-1, MM proliferation can be decreased and apoptosis can be induced. Next, using the GEO database, we found that Mcl-1 was increased in MMs. Mcl-1 overexpression counterbalanced the tumor suppressing effect of siHIF-1 alpha on MM apoptosis. Additionally, HIF-1 alpha acting as a transcription factor, could directly target the promoter region of Mcl-1 to promote Mcl-1 expression. Based on the experimental result, our find-ings strongly suggest that HIF-1 alpha regulated the progression of MMs by directly targeting the Mcl-1.
引用
收藏
页码:1483 / +
页数:10
相关论文
共 50 条
  • [1] Targeting Mcl-1 for the therapy of cancer
    Quinn, Bridget A.
    Dash, Rupesh
    Azab, Belal
    Sarkar, Siddik
    Das, Swadesh K.
    Kumar, Sachin
    Oyesanya, Regina A.
    Dasgupta, Santanu
    Dent, Paul
    Grant, Steven
    Rahmani, Mohamed
    Curiel, David T.
    Dmitriev, Igor
    Hedvat, Michael
    Wei, Jun
    Wu, Bainan
    Stebbins, John L.
    Reed, John C.
    Pellecchia, Maurizio
    Sarkar, Devanand
    Fisher, Paul B.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2011, 20 (10) : 1397 - 1411
  • [2] Salinomycin inhibits breast cancer progression via targeting HIF-1α/VEGF mediated tumor angiogenesis in vitro and in vivo
    Dewangan, Jayant
    Srivastava, Sonal
    Mishra, Sakshi
    Divakar, Aman
    Kumar, Sadan
    Rath, Srikanta Kumar
    BIOCHEMICAL PHARMACOLOGY, 2019, 164 : 326 - 335
  • [3] Targeting MCL-1 in cancer: current status and perspectives
    Haolan Wang
    Ming Guo
    Hudie Wei
    Yongheng Chen
    Journal of Hematology & Oncology, 14
  • [4] Targeting MCL-1 in cancer: current status and perspectives
    Wang, Haolan
    Guo, Ming
    Wei, Hudie
    Chen, Yongheng
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2021, 14 (01)
  • [5] Mcl-1 Inhibition: Managing Malignancy in Multiple Myeloma
    Al-Odat, O. S.
    von Suskil, M.
    Chitren, R. J.
    Elbezanti, W. O.
    Srivastava, S. K.
    Budak-Alpddogan, T.
    Jonnalagadda, S. C.
    Aggarwal, B. B.
    Pandey, M. K.
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [6] Mcl-1 Inhibition: Managing Malignancy in Multiple Myeloma
    Al-Odat, Omar
    von Suskil, Max
    Chitren, Robert
    Elbezanti, Weam
    Srivastava, Sandeep
    Budak-Alpddogan, Tulin
    Jonnalagadda, Subash
    Aggarwal, Bharat
    Pandey, Manoj
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [7] miR-497 suppresses angiogenesis in breast carcinoma by targeting HIF-1α
    Wu, Zhihao
    Cai, Xuehong
    Huang, Chengang
    Xu, Jia
    Liu, An
    ONCOLOGY REPORTS, 2016, 35 (03) : 1696 - 1702
  • [8] Repression of Mcl-1 and disruption of the Mcl-1/Bak interaction in myeloma cells couple ER stress to mitochondrial apoptosis
    Gomez-Bougie, Patricia
    Halliez, Maxime
    Moreau, Philippe
    Pellat-Deceunynck, Catherine
    Amiot, Martine
    CANCER LETTERS, 2016, 383 (02) : 204 - 211
  • [9] Toward Targeting Antiapoptotic MCL-1 for Cancer Therapy
    Kelly, Gemma L.
    Strasser, Andreas
    ANNUAL REVIEW OF CANCER BIOLOGY, VOL 4, 2020, 4 : 299 - 313
  • [10] MicroRNA-133a, downregulated in osteosarcoma, suppresses proliferation and promotes apoptosis by targeting Bcl-xL and Mcl-1
    Ji, Fang
    Zhang, Hao
    Wang, Yang
    Li, Ming
    Xu, Weidong
    Kang, Yifan
    Wang, Zhiwei
    Wang, Zimin
    Cheng, Ping
    Tong, Dake
    Li, Cheng
    Tang, Hao
    BONE, 2013, 56 (01) : 220 - 226